IMPACT Trial: Intervention to iMProve AdherenCe equitably

Contact:

Protocol:

AAAT8817

Study Status:

Active/Enrolling

Population:

Adult

Phase:

NA

Many patients with breast cancer, who also take medicine to prevent heart disease such as a blood pressure medicine or a cholesterol medicine, experience frustration with the large number and difficult scheduling of their medications, known as “pill burden”. This study will help us find out how much “pill burden” exists in subjects with cancer at various stages, and how this intervention can help. Results of this study may help us figure out the best way to help patients manage their medications in the future.

Are you Eligible? (Inclusion Criteria)

  • Are you diagnosed with stage I- III breast cancer?
  • Do you speak English?
  • Are you taking medication for your cardiovascular disease?

Specialty Area(s)

Principal Investigator

Profile Headshot
  • Director, Breast Oncology
  • Co-leader, Cancer Population Sciences Program, Herbert Irving Comprehensive Cancer Center
  • Deputy Director for Cancer Care Delivery and Research
  • Interim Chief, Division Hematology/Oncology

Trial Location(s)

CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032